Skip to content
Company Analysis

CVS Health Corporation CVS

A comprehensive view of key metrics, scores, and financial health for CVS Health Corporation

Overview of CVS Health Corporation

CVS NYQ
Healthcare Healthcare Plans Large Cap
CVS Health Corporation (CVS), is a Large Cap company, in the Healthcare Plans industry, last closed at $76.13, about 686.5% undervalued vs fair value, +14.2% 1Y return, placing in the top 25% of its sector.
$76.13
0.08%
As of March 13, 2026
Previous close • Vol 90d: 35.7%
52-Week Range
Market Cap
$96.85B
Enterprise Value
$181.93B
Overall Score
Scores locked

Create a free account to see overall and pillar scores for CVS Health Corporation.

Top Beats

Quick Facts

Website https://www.cvshealth.com
HQ Woonsocket, RI
Employees 219,000
Fiscal year Dec 31

Next Events

No upcoming events available.

Fair Value Snapshot

Bear Base Bull
$529
$599
$676
Current: $76.13 +687% vs base

Engine Room Money Flow™

Large Cap

Corporate Free Cash Flow - Where revenue goes and how value is created

Flow Steps
Revenue
372.81B
7.8%%
Gross Profit
51.40B
7.7%%
Operating Income
9.79B
21.9%%
Net Income
4.61B
-97.7%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Corporate Free Cash Flow

Quality & Reliability Indicators

Cash Conversion Ratio
357.8%
Excellent

FCF / Net Income - measures how well earnings convert to cash

Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium

Owner's Pocket - Capital Allocation

Total Returned to Shareholders

Combined dividends, buybacks, and debt reduction

$3.8B
59.9% of FCF

Where It Leaks

Cash Flow Health some concerns
Moderate efficiency issues detected. Review active leaks below for improvement areas.
2
Active Leaks
0/2
Improving
1
High Impact
0
Critical
Locked Leak
Upgrade to view details
Premium
Moat Analysis Corporate Default

Competitive Advantage Assessment

Evaluating CVS Health Corporation's durable competitive advantages across 6 defense dimensions

Overall Moat Strength
30
/100
Developing
Scores based on quantitative metrics and qualitative factors

Upgrade to unlock interactive defense details

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power

Developing
34
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Generic Industrial / Default vs Industry Peers 87% Coverage
Trade-Off Triangle Visualization A ternary plot showing CVS's balance between Growth (38.2%), Profitability (29.3%), and Safety (32.5%). Growth 38% Safety 33% Profitability 29%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

64th percentile vs peers
64
Key Signals
Revenue CAGR 3Y 73.7% 90p EPS Growth YoY 8.31 88p EPS CAGR 3Y 1.16 85p TSR 82.8% 83p Rev Growth YoY 7.8% 10p
Strengths
  • Revenue Cagr 3Y in top 20% of peers (73.7%, 90th percentile)
  • Eps Growth Yoy in top 20% of peers (8.31, 88th percentile)
  • Eps Cagr 3Y in top 20% of peers (1.16, 85th percentile)
  • D/E Ratio in top 20% of peers (1.24, 90th percentile)
  • Growth above peer median with strong metric coverage (100%)
Risks
  • Rev Growth Yoy in bottom 20% of peers (7.8%)

Profitability

49th percentile vs peers
49
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

54th percentile vs peers
55
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for CVS Health Corporation.

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$598.76
- - -
+686.5% vs current
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info